Home › Funds › Atom Investors LP › IMNM

Atom Investors LP position in IMNM

IMMUNOME INC · Health Care

Atom Investors LP reported holding 608,277 shares of IMNM (IMMUNOME INC) in its Q3 2026 13F filing — a position valued at US$13.1M, representing 0.90% of its reported portfolio and ranking #8 among its reported holdings. Atom Investors LP has disclosed IMNM holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)608.28K sh
Reported value held$13.08M
Portfolio Weight0.90%
First reportedQ4 2025
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Atom Investors LP's IMNM position evolved

Atom Investors LP first disclosed a stake in IMNM in Q4 2025 at 175,767 shares (US$3.8M). The position peaked in Q3 2026 at 608,277 shares, worth US$13.1M. Across 4 filings, Atom Investors LP increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 608,277 shares valued at US$13.1M — an increase of 310,788 shares quarter over quarter.. Notable position changes include a 75% increase in Q1 2026 (shares fell 3% over the following quarter), a 104% increase in Q3 2026 (shares fell 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 175.77K $3.78M New
Q1 2026 306.88K $6.71M Add
Q2 2026 297.49K $6.30M Reduce
Q3 2026 608.28K $13.08M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IMNM and 13F data

IMNM (IMMUNOME INC) is a Health Care company. 43 other funds we track also report a position in IMNM — the largest reported positions include DRIEHAUS CAPITAL MANAGEMENT LLC (US$107.1M), Redmile Group, LLC (US$104.1M), Enavate Sciences GP, LLC (US$76.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IMNM

All IMNM fund holders →

FAQ

How long has Atom Investors LP held IMNM?

Atom Investors LP has disclosed IMNM holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Atom Investors LP's current position in IMNM?

As of Q3 2026, Atom Investors LP holds 608.28K shares of IMNM (IMMUNOME INC), valued at $13.08M, representing 0.90% of its reported portfolio and ranking #8.

Has Atom Investors LP been buying or selling IMNM?

In the latest 13F filing (Q3 2026), Atom Investors LP increased its position in IMNM. The position peaked in Q3 2026 at 608.28K shares.

Which other funds hold IMNM?

Other major institutional holders of IMNM include DRIEHAUS CAPITAL MANAGEMENT LLC, Redmile Group, LLC, Enavate Sciences GP, LLC, among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.